ATE151977T1 - Therapeutisch wirksame, örtliche anwendung von st1435 - Google Patents

Therapeutisch wirksame, örtliche anwendung von st1435

Info

Publication number
ATE151977T1
ATE151977T1 AT91912052T AT91912052T ATE151977T1 AT E151977 T1 ATE151977 T1 AT E151977T1 AT 91912052 T AT91912052 T AT 91912052T AT 91912052 T AT91912052 T AT 91912052T AT E151977 T1 ATE151977 T1 AT E151977T1
Authority
AT
Austria
Prior art keywords
therapeutically effective
topical application
skin
blood
nopregnene
Prior art date
Application number
AT91912052T
Other languages
English (en)
Inventor
Alfred Moo-Young
Ana Zepeda-Ortega
Horacio Bruno Croxatto
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Application granted granted Critical
Publication of ATE151977T1 publication Critical patent/ATE151977T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT91912052T 1990-06-01 1991-05-24 Therapeutisch wirksame, örtliche anwendung von st1435 ATE151977T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53221590A 1990-06-01 1990-06-01

Publications (1)

Publication Number Publication Date
ATE151977T1 true ATE151977T1 (de) 1997-05-15

Family

ID=24120850

Family Applications (2)

Application Number Title Priority Date Filing Date
AT91912052T ATE151977T1 (de) 1990-06-01 1991-05-24 Therapeutisch wirksame, örtliche anwendung von st1435
AT96201585T ATE220912T1 (de) 1990-06-01 1991-05-24 Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT96201585T ATE220912T1 (de) 1990-06-01 1991-05-24 Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung

Country Status (10)

Country Link
US (1) US5651973A (de)
EP (3) EP0754456B1 (de)
JP (1) JP2625254B2 (de)
AT (2) ATE151977T1 (de)
CA (1) CA2083404C (de)
DE (2) DE69133077T2 (de)
DK (2) DK0754456T3 (de)
ES (2) ES2099747T3 (de)
GR (1) GR3023312T3 (de)
WO (1) WO1991018570A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2083404C (en) * 1990-06-01 2001-02-20 Alfred Moo-Young Therapeutically effective topical application of st1435
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US8529807B2 (en) * 2002-01-17 2013-09-10 Lts Lohmann Therapie-Systeme Ag Method for neutralizing or recycling carrier materials for film-like coatings
GB2389793A (en) * 2002-06-18 2003-12-24 Euro Celtique Sa Transdermal delivery system
US20040057983A1 (en) 2002-09-25 2004-03-25 David Schmidt Biomolecular wearable apparatus
DK2450041T3 (en) 2005-10-12 2018-11-19 Unimed Pharmaceuticals Llc Enhanced testosterone gel for use in the treatment of hypogonadism
US8602961B2 (en) 2008-05-15 2013-12-10 Lifewave Products Llc Apparatus and method of stimulating elevation of glutathione levels in a subject
US20110220817A1 (en) * 2008-08-12 2011-09-15 Moore John W Method of reducing the distortion of the electromagnetic field
NZ600907A (en) 2009-12-17 2013-11-29 Population Council Inc Progestin/estradiol transdermal gel
US10322063B2 (en) 2013-03-19 2019-06-18 Genovus Biotechnologies Inc. Muscle optimization device and method
US10888707B2 (en) 2013-03-19 2021-01-12 Genovus Biotechnologies Inc. Muscle optimization device and method
AU2015353728B2 (en) 2014-11-25 2021-03-11 Buckman Laboratories International, Inc. Felt conditioner and cleaner

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543245C3 (de) * 1965-11-26 1974-07-18 Merck Patent Gmbh, 6100 Darmstadt 16-Methy len-19-norprogesteronderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
NL6902314A (de) * 1969-02-13 1970-08-17
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag
EP0394429B1 (de) * 1988-10-27 1996-01-10 Schering Aktiengesellschaft Mittel zur transdermalen applikation enthaltend gestoden
WO1991018572A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Device for transdermal administration of drugs
CA2083404C (en) * 1990-06-01 2001-02-20 Alfred Moo-Young Therapeutically effective topical application of st1435
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices

Also Published As

Publication number Publication date
DE69125855D1 (de) 1997-05-28
DK0754456T3 (da) 2002-11-11
DE69125855T2 (de) 1997-07-31
EP0600873A1 (de) 1994-06-15
JPH07502253A (ja) 1995-03-09
EP0754456B1 (de) 2002-07-24
US5651973A (en) 1997-07-29
JP2625254B2 (ja) 1997-07-02
ATE220912T1 (de) 2002-08-15
WO1991018570A1 (en) 1991-12-12
DE69133077T2 (de) 2002-11-07
CA2083404C (en) 2001-02-20
GR3023312T3 (en) 1997-08-29
EP1093816A2 (de) 2001-04-25
ES2099747T3 (es) 1997-06-01
EP0600873B1 (de) 1997-04-23
DE69133077D1 (de) 2002-08-29
EP0754456A2 (de) 1997-01-22
ES2180690T3 (es) 2003-02-16
EP0600873A4 (de) 1993-09-02
DK0600873T3 (da) 1997-05-20
EP0754456A3 (de) 2000-02-02
CA2083404A1 (en) 1991-12-02
EP1093816A3 (de) 2003-10-22

Similar Documents

Publication Publication Date Title
ATE151977T1 (de) Therapeutisch wirksame, örtliche anwendung von st1435
ATE196082T1 (de) Stickstoffoxyd abgebendes präparat zur behandlung von analen erkrankungen
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
DK0682514T3 (da) Anvendelse af lokalanæstetiske midler til fremstilling af et lægmiddel til behandling af bronchial astma
ATE107517T1 (de) Transdermales therapeutisches mittel.
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
ES550011A0 (es) Un metodo de administracion de una cantidad terapeuticamenteefectiva de timolol
IT1221826B (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
IT1057132B (it) Bendaggio stratificato per la somministrazione di scopolamina per via transdermica
DK1383540T3 (da) Fremgangsmdåer og farmaceutiske sammensætninger til sårheling
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
IE780497L (en) Broparestrol based therapeutic compositions
ATE435023T1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
RU96104062A (ru) Средство "витадерм" в комплексной терапии ожоговых ран
IT7826263A0 (it) Derivati del piranocromone e composizione terapeutica comprendente gli stessi, per il trattamento di malattie allergiche.
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
IT8024862A0 (it) L'applicazione in terapeutica come agenti analgesici dei derivati del 4,5,6,7-tetraidroisossazolo (5,4-c)piridin-3-ol
SU1095491A1 (ru) Средство дл лечени кардиалгий и легких форм ишемической болезни сердца "мебикар
IT1291307B1 (it) Composizione farmaceutica atta al trattamento delle patologie neurodegenerative
RU99122488A (ru) Способ лечения рака эндометрия
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)
JPS5231822A (en) Manufacturing pharmaceutical preparatios for rectal administration

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time